SCHEMBL4746005

SCHEMBL4746005

O=NS(=O)(=O)C1NCc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.34
CYP3A4 P08684 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DRD1 P21728 6/20 0.33
DRD2 P14416 4/20 0.33
DRD4 P21917 4/20 0.33
MAPK1 P28482 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
TP53 P04637 2/20 0.33
CYP1A2 P05177 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
CYP2C19 P33261 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29035907 0.80 CA1 (0.38) CYP2D6CYP3A4MEN1KMT2ADRD1
SCHEMBL28267065 0.79 PNMT (0.37) CYP2D6CYP3A4MEN1KMT2ADRD1
SCHEMBL30804802 0.79 ALDH1A1 (0.38) CYP2D6CYP3A4MEN1KMT2ADRD1
SCHEMBL6920787 0.79 CA1 (0.40) CYP2D6CYP3A4MEN1KMT2ADRD1
SCHEMBL2695009 0.76 ALDH1A1 (0.37) ALDH1A1MAPTKDM4E
SCHEMBL29383585 0.71 ALDH1A1 (0.45) KMT2AALDH1A1MAPTTP53LMNA
SCHEMBL5708850 0.71 ALDH1A1 (0.45) KMT2AALDH1A1MAPTTP53LMNA
SCHEMBL29644910 0.68 HTR6 (0.42) MEN1KMT2APKMTSHR
SCHEMBL359802 0.67 MAPK1 (0.42) CYP2D6CYP3A4MEN1KMT2ADRD1
SCHEMBL9009806 0.64 HTR2A (0.40) CYP2D6CYP3A4MEN1KMT2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013016441-A1 HIV INTEGRASE INHIBITORY OXOISOINDOLINE SULFONAMIDES The United States of America, represented by The Secretary, Department of Health & Human Services (US) 2013-01-31 WO claimed
WO-2013016441-A1 HIV INTEGRASE INHIBITORY OXOISOINDOLINE SULFONAMIDES The United States of America, represented by The Secretary, Department of Health & Human Services (US) 2013-01-31 WO disclosed
WO-2008124518-A1 OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 WO disclosed
WO-2008124518-A1 OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 WO disclosed